`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`JAZZ PHARMACEUTICALS, INC. et al.,
`
`Plaintiffs,
`
`v.
`
`AMNEAL PHARMACEUTICALS LLC,
`
`Civil Action No.
`2:13-00391 (ES)(JAD)
`
`ORDER GRANTING
`MOTION TO SEAL
`
`Defendant.
`
`DOCUMENT ELECTRONICALLY FILED
`
`THIS MATTER having been opened to the Court by Plaintiff Jazz Pharmaceuticals,
`
`Inc. ("Jazz"), by and through their counsel, in connection with Jazz's Motion to Seal (ECF No.
`
`254), pursuant to Local Civil Rule 5.3(c); and the Court having considered the papers submitted
`
`by Jazz in support of its Motion; and papers submitted by Defendant Par Pharmaceutical, Inc .
`
`. ("Par") in further support thereof; and the Court having been notified by Par of the information
`
`which Par has designated Highly Confidential; and the Court having considered and adopted the
`
`Declaration of Bradford C. Frese, the Court makes the following Findings of Fact and
`
`Conclusions of Law:
`
`•
`
`Jazz's February 11, 2016 letter to the Honorable Joseph A. Dickson (ECF No.
`::J.l Lt
`•)("Jazz's February 11 Letter") refers to confidential technical and business
`
`information that has been designated as "HIGHLY CONFIDENTIAL-SUBJECT
`
`TO DISCOVERY CONFIDENTIALITY ORDER" by Par under the Discovery
`
`Confidentiality Order entered in this action (ECF No. 144);
`
`• The information in Jazz's February 11 Letter that Par aims to seal refers to and
`
`relates to confidential and proprietary information concerning, among other
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 287 Filed 05/17/16 Page 2 of 3 PageID: 5403
`
`things, Par's ANDA. Public disclosure of such confidential information would
`
`permit competitors to potentially (and likely) use such information to Par's
`
`detriment. Par has a legitimate interest in protecting the confidentiality of its
`
`trade secret and other confidential research, development, commercial, and
`
`technical information;
`
`• Public disclosure of Par's information would cause Par significantharm because
`
`public disclosure of this trade secret and other confidential research,
`
`development, commercial, and technical information would provide the public
`
`insight into the business and operations of Par, its processes in considering and
`
`developing its proprietary technology, and would give competitors an unfair
`
`advantage;
`
`• Sealing such materials is the least restrictive alternative because it only includes
`
`information Par has identified and designated as "HIGHLY CONFIDENTIAL-
`
`SUBJECT TO DISCOVERY CONFIDENTIALITY ORDER" in this action.
`
`Therefore, the Court having found that there are legitimate public and private interests
`~~
`which warrant the relief sought, IT IS on this\~ """' day of ~\ 2016,
`
`ORDERED that Jazz's Motion to Seal, pursuant to Local Civil Rule 5.3(c) (ECF No.
`
`254), is hereby GRANTED; and it is further
`
`ORDERED that the unredacted February 11 Letter (ECF No. 214) shall be sealed and
`
`maintained under seal by the Court; and it is further
`
`ORDERED that the Clerk of the Court shall maintain on the docket a public copy of
`
`Jazz's February 11 Letter (ECF No. 255) redacted as consistent with this Order.
`
`2
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 287 Filed 05/17/16 Page 3 of 3 PageID: 5404
`Case 2:13-cv-00391-ES-JAD Document 287 Filed 05/17/16 Page 3 of 3 PageID: 5404
`
`
`
`LE JOSEPH A. DICKSON
`UNIT D STATES MAGISTRATE JUDGE
`
`3
`
`